Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Wyeth wins European approval for osteoporosis drug
The World Health Organization’s fracture risk treatment guidelines and assessment tool for calculating a woman’s risk of experiencing an osteoporotic fracture were used in analyses of clinical data
The World Health Organization’s fracture risk treatment guidelines and assessment tool for calculating a woman’s risk of experiencing an osteoporotic fracture were used in analyses of clinical data
Novo Nordisk plans to use Phase Forward’s InForm electronic data capture product as the default data capture system across all clinical trial phases, from Phases I through IV.
HearUSA has also licensed certain software and intellectual property for the purposes of the continued conduct of the Canadian business and agreed not to compete in Canada for
Mr Reinhardt joins ATS Medical with over 20 years of medical device sales and marketing experience, having previously served in senior management level positions at other medical technology
Dr Kelsey will manage the operational and strategic activities of the company’s oncology programs. He will report to Thomas Okarma, Geron’s president and CEO. Mr Movahhed will be
This will be in combination with substantial investment on clinical research for generating India-specific data for both, new product development, and marketing existing products. The company plans to
In the first quarter of 2009, the company revenue increase was primarily due to $76.9 million of incremental revenue provided by our Health Management segment principally as a
The Phase III studies, known as Achieve 1 and Achieve 2/3, evaluated albinterferon alfa-2b versus peginterferon alfa-2a, in combination with ribavirin, for use in the treatment of interferon-naive
In this study, Omnaris HFA met its primary efficacy endpoint by demonstrating a statistically significant reduction in the 24-hour reflective total nasal symptom score (TNSS), which assesses the
Marcus Hedenskog, head of the newly formed Vitrolife KK, said: “The establishment of a company of our own, with an office in Tokyo, will markedly increase our opportunities